TMO vs REGN
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Regeneron Pharmaceuticals, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | REGN |
|---|---|---|
| Price | $700.22 | $955.47 |
| Market cap | $259.44B | $98.84B |
| P/E ratio | 36.9 | 21.1 |
| ROE | 13.38% | 14.95% |
| Profit margin | 14.94% | 28.51% |
| Revenue growth | 9.10% | 36.30% |
| Dividend yield | 0.27% | 0.39% |
| Beta | 0.84 | 0.10 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs REGN in plain English
- TMO is the bigger company — about 2.6× the market cap of REGN.
- REGN is cheaper on earnings (P/E 21.1 vs 36.9).
- REGN earns a higher return on equity (15% vs 13%).
- REGN is growing revenue faster (36% vs 9%).
- REGN has the higher dividend yield (0.39% vs 0.27%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
REGN return calculator
See what $1,000 in Regeneron Pharmaceuticals, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.